Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study.

PubWeight™: 1.84‹?› | Rank: Top 3%

🔗 View Article (PMID 11257253)

Published in Atherosclerosis on February 15, 2001

Authors

C Lahoz1, E J Schaefer, L A Cupples, P W Wilson, D Levy, D Osgood, S Parpos, J Pedro-Botet, J A Daly, J M Ordovas

Author Affiliations

1: Lipid Metabolism Laboratory, Jean Mayer-USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington St, Boston, MA 02111, USA.

Articles citing this

The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports. BMC Med Genet (2007) 5.02

Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol (2013) 4.16

A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35

Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25

Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry (2008) 1.24

An Update on Postoperative Cognitive Dysfunction. Adv Anesth (2010) 1.12

Gene-gene and gene-environment interactions: new insights into the prevention, detection and management of coronary artery disease. Genome Med (2009) 1.12

Molecular mechanism of apolipoprotein E binding to lipoprotein particles. Biochemistry (2009) 1.11

Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER. Atherosclerosis (2008) 1.06

The role of lipid-related genes, aging-related processes, and environment in healthspan. Aging Cell (2013) 1.05

Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan. Aging Cell (2011) 1.03

Apolipoprotein E genotype, dementia, and mortality in the oldest old: the 90+ Study. Alzheimers Dement (2012) 0.97

Molecular genetics of atherosclerosis. Hum Genet (2009) 0.95

Age, gender, and cancer but not neurodegenerative and cardiovascular diseases strongly modulate systemic effect of the Apolipoprotein E4 allele on lifespan. PLoS Genet (2014) 0.93

Molecular basis for the differences in lipid and lipoprotein binding properties of human apolipoproteins E3 and E4. Biochemistry (2010) 0.93

Molecular genetics of myocardial infarction. Genomic Med (2008) 0.91

Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly. J Lipid Res (2009) 0.91

Selection on alleles affecting human longevity and late-life disease: the example of apolipoprotein E. PLoS One (2010) 0.90

Effects of apolipoprotein E-epsilon4 and -epsilon2 in amnestic mild cognitive impairment and dementia in Shanghai: SCOBHI-P. Am J Alzheimers Dis Other Demen (2010) 0.89

Relationship between ApoE gene polymorphism and coronary heart disease in Gaza Strip. J Cardiovasc Dis Res (2011) 0.86

Alzheimer's disease susceptibility genes APOE and TOMM40, and brain white matter integrity in the Lothian Birth Cohort 1936. Neurobiol Aging (2014) 0.86

Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly. Curr Cardiovasc Risk Rep (2010) 0.86

Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis. Sci Rep (2014) 0.85

Pleiotropic Associations of Allelic Variants in a 2q22 Region with Risks of Major Human Diseases and Mortality. PLoS Genet (2016) 0.84

Trade-off in the effect of the APOE gene on the ages at onset of cardiocascular disease and cancer across ages, gender, and human generations. Rejuvenation Res (2013) 0.83

Inflammatory gene variants in the Tsimane, an indigenous Bolivian population with a high infectious load. Biodemography Soc Biol (2011) 0.83

ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60. J Acquir Immune Defic Syndr (2016) 0.83

Age, APOE and sex: Triad of risk of Alzheimer's disease. J Steroid Biochem Mol Biol (2016) 0.82

The potential applications of Apolipoprotein E in personalized medicine. Front Aging Neurosci (2014) 0.81

EFFECT OF THE APOE ε4 ALLELE AND COMBAT EXPOSURE ON PTSD AMONG IRAQ/AFGHANISTAN-ERA VETERANS. Depress Anxiety (2015) 0.81

Job strain and cognitive decline: a prospective study of the framingham offspring cohort. Int J Occup Environ Med (2015) 0.81

Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients. Lipids Health Dis (2014) 0.79

Apolipoprotein E and measured physical and pulmonary function in older Taiwanese adults. Biodemography Soc Biol (2013) 0.79

Interaction of gender and body mass index (BMI) reveals evidence of linkage for hypertension in the Framingham Heart Study. BMC Genet (2003) 0.79

Influence of Abdominal Obesity on the Lipid-Lipoprotein Profile in Apoprotein E2/4 Carriers: The Effect of an Apparent Duality. J Lipids (2015) 0.78

Apolipoprotein E genotype, lipid levels and coronary heart disease in a Polish population group. Eur J Epidemiol (2001) 0.78

Sex hormones and macronutrient metabolism. Crit Rev Food Sci Nutr (2015) 0.78

Apolipoprotein E is associated with blood lipids and inflammation in Taiwanese older adults. Atherosclerosis (2011) 0.78

Carbohydrate intake modifies associations between ANGPTL4[E40K] genotype and HDL-cholesterol concentrations in White men from the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis (2008) 0.77

Apolipoprotein E gene polymorphism in nonalcoholic fatty liver disease. Dig Dis Sci (2007) 0.77

Sex-specific interaction between APOE genotype and carbohydrate intake affects plasma HDL-C levels: the Strong Heart Family Study. Genes Nutr (2008) 0.77

Birth Cohort, Age, and Sex Strongly Modulate Effects of Lipid Risk Alleles Identified in Genome-Wide Association Studies. PLoS One (2015) 0.77

Male-specific association between a gamma-secretase polymorphism and premature coronary atherosclerosis. PLoS One (2008) 0.77

The influence of ApoE genotype on the lipid profile and lipoproteins during normal pregnancy in a Southern African population. Afr Health Sci (2016) 0.77

Is the distinction between Alzheimer's disease and vascular dementia possible and relevant? Dialogues Clin Neurosci (2003) 0.76

Association between Apolipoprotein E polymorphism and myocardial infarction risk: A systematic review and meta-analysis. FEBS Open Bio (2015) 0.76

ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment. Atherosclerosis (2014) 0.76

APOE alleles are not associated with calcific aortic stenosis. Heart (2006) 0.75

Myocardial infarction in the Wisconsin Longitudinal Study: the interaction among environmental, health, social, behavioural and genetic factors. BMJ Open (2017) 0.75

Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status. Int J Environ Res Public Health (2014) 0.75

Matters of the heart transcriptome: a brief history of cardiovascular genomics. Tex Heart Inst J (2002) 0.75

APOE and FABP2 Polymorphisms and History of Myocardial Infarction, Stroke, Diabetes, and Gallbladder Disease. Cholesterol (2011) 0.75

Protective effects of APOE e2 against disease progression in subcortical vascular mild cognitive impairment patients: A three-year longitudinal study. Sci Rep (2017) 0.75

Alzheimer's disease genetic risk variants beyond APOE ε4 predict mortality. Alzheimers Dement (Amst) (2017) 0.75

Association of APOE gene polymorphism with lipid profile and coronary artery disease in Afro-Caribbeans. PLoS One (2017) 0.75

Detection of Apolipoprotein E Gene Polymorphism and Blood Lipid Level in Hemodialysis Patients. J Clin Med Res (2017) 0.75

Apolipoprotein E polymorphism and clinical course in childhood nephrotic syndrome. Pediatr Nephrol (2003) 0.75

Articles by these authors

Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81

Cardiovascular disease risk profiles. Am Heart J (1991) 21.65

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93

Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA (1997) 17.88

An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63

Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med (1999) 9.83

Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24

Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84

The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01

Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54

The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38

Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00

A randomized trial of treatment options for alcohol-abusing workers. N Engl J Med (1991) 6.94

Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76

Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72

STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32

The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22

Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00

Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63

BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59

Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med (1987) 5.58

Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43

Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23

Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11

Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04

Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01

Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74

Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63

Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52

Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44

The somatic replication of DNA methylation. Cell (1981) 4.42

Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36

Inverse association of dietary fat with development of ischemic stroke in men. JAMA (1998) 4.20

Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12

Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08

Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05

Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04

The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04

Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96

The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93

Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81

Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80

Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68

An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66

Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61

Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60

Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57

The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47

Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44

Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44

Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol (1986) 3.35

NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33

INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23

Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19

Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation (2001) 3.18

Prevention of childhood injuries: evaluation of the Statewide Childhood Injury Prevention Program (SCIPP). Am J Public Health (1989) 3.17

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA (2001) 3.12

Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial. JAMA (1994) 3.11

Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09

Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09

Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08

Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08

Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07

Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00

ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95

Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92

Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91

Cardiorespiratory events recorded on home monitors: Comparison of healthy infants with those at increased risk for SIDS. JAMA (2001) 2.87

Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86

Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81

Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81

Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71

Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71